A drying expiratory limb of a breathing circuit is provided that is configured to increase or optimize drying of a gas to reduce or prevent condensation. The drying expiratory limb can include a wall that is at least partly made of a breathable material configured to allow transmission of water vapor but substantially prevent transmission of liquid water. The wall includes first and second openings in the wall, the openings respectively configured to receive a gas at a first temperature and a first relative humidity and to allow the gas to exit having a second temperature and a second relative humidity. The drying expiratory limb can be configured to tailor the temperature drop of the gas along the wall to maintain a relative humidity within a targeted range and/or to maintain the gas temperature above its dew point temperature.

The present invention aims to provide a method for producing a microneedle device comprising a coating comprising dexmedetomidine and isoproterenol, in which the stability of isoproterenol during production and after production of the microneedle device is high. A method for producing a microneedle device according to one embodiment of the present invention comprises coating microneedles with a coating liquid to form a coating on the microneedles. The microneedle device comprises a substrate, microneedles disposed on the substrate, and a coating formed on the microneedles. The coating liquid comprises dexmedetomidine or a pharmaceutically acceptable salt thereof, isoproterenol or a pharmaceutically acceptable salt thereof, ethylenediaminetetraacetic acid or a pharmaceutically acceptable salt thereof, and a sulfated polysaccharide.

The invention relates to a patient interface comprising a plenum chamber, a seal-forming structure, and a positioning and stabilizing structure, as well as the method of operating the patient interface. The patient's interface is configured to leave a patient's mouth uncovered or if the seal-forming structure is configured to seal around a patient's nose and mouth, the patient interface is configured to allow the patient to breath from the ambient in an absence of the flow of pressurized. The positioning and stabilizing structure includes headgear, and the seal-forming structure and at least a portion of the headgear is formed from a one piece construction of textile material. In another embodiment, the seal-forming structure and/or the positioning and stabilizing structure includes an adaptive portion that adjusts based on usage conditions. In another embodiment, the positioning and stabilizing structure, the seal-forming structure and/or the plenum chamber includes and/or is formed of a textile material, and the textile material includes at least one magnetic thread constructed of magnetic material to provide a magnetic interaction between a first part of the patient interface and a second part of the patient interface. In another embodiment, a stiffener is coupled to the plenum chamber, the seal-forming structure, and/or the positioning and stabilizing structure. In another embodiment, at least one of the plenum chamber and the seal-forming structure includes a textile material; and wherein the textile material includes a surface structure that limits adhesion of debris. A UV cleaning receptacle of the patient interface is also disclosed.

The disclosure relates to a syringe, comprising a syringe body with a nozzle and a threaded connection. The syringe body comprises a side wall and a front wall, wherein the syringe body comprises a cycloolefin as a first material, at least in portions. The first material forms an internal wall of the syringe body. The threaded connection comprises, at least in portions, as a second material a material other than the cycloolefin, wherein the first and the second material are integrally bonded to one another. The second material extends in the region of the front wall at least in portions over the first material, so that the front wall comprises, at least in portions, a two-layer region. The first and the second material in the two-layer region have a mutually engaging structure.

A ventilation treatment device and a ventilation-control method are provided. During use, when a headband contacts a headrest, a first valve assembly contacts a second valve assembly to open first air holes and second air holes, thereby communicating a first chamber with a second chamber, such that air from an air source into the first chamber enters the second chamber and further enters a respiratory chamber of a patient connecting apparatus for inhalation by a patient; and when the headband is separated from the headrest, the first valve assembly and the second value assembly are separated to close the first air holes and the second air holes, thereby preventing the air in the first chamber and the second chamber from flowing out through the first air holes and the second air holes, respectively.

A cleanable respiratory tube is provided. The cleanable respiratory tube comprises a corrugated tube adapted for conveying gases to and/or from a patient. The corrugated tube has a first and a second fitting at a first and a second end thereof, respectively. A sheath having a smooth cleanable outer surface encases the corrugated tube. A first and a second end of the sheath is fixedly attached to the respective first and second fitting. The sheath is made of a flexible foil-type sheet material surrounding the corrugated tube having an inside diameter approximately equal to an outside diameter of ridges of the corrugated tube such that the sheath is in a touching relationship therewith.

A universal respiratory detector for detecting a respiratory gas. The universal respiratory detector may include a plurality of layers with a visual indicator to quickly and reversibly change color to detect a respiratory gas parameter such as carbon dioxide. The color change may be visible from both sides of the detector. In some examples, the respiratory detector may be a biocompatible and conformable sticker for mounting on a person's face or an oxygen delivery device.

A syringe (1) comprises a barrel (2), a stopper (3) and a plunger (4). The barrel (2) has a hollow interior, an orifice (21) and an opening (22) opposite to the orifice (21). The stopper (3) is arranged in the hollow interior of the barrel (2) thereby defining a sealed chamber (5) in the interior of the barrel (2). The stopper (3) is displaceable in the interior of the barrel (2) thereby varying a volume of the chamber (5). The plunger (4) extends through the opening (22) of the barrel (2) into the hollow interior of the barrel (2). The plunger (4) has a distal end (41) outside of the barrel (2) and a proximal end (42) inside the hollow interior of the barrel (2). The stopper (3) has a distal face (31) directed towards the plunger (4), a proximal face (32) directed towards the chamber (5) and an internal cavity (33) opening at the distal face (31). The syringe (1) is equipped with a sealing structure sealing the cavity (33) of the stopper (3) such that the cavity (33) of the stopper (3) is microbiologically sealed.

Apparatus and methods are described for use with a portion of plant material that includes at least one active ingredient. A vaporizing unit includes a heating element configured to heat the plant material, and a sensor configured to detect an indication of airflow rate through the vaporizing unit. Control circuitry is configured to receive an indication of the airflow rate through the vaporizing unit, and, in response thereto, to determine a smoking profile that is desired by the user. The control circuitry drives the heating element to vaporize the active ingredient of the plant material by heating the plant material according to the determined smoking profile. The control circuitry dynamically updates the smoking profile in response to changes in airflow rate over the course of a smoking session. Other applications are also described.

The present disclosure provides an aerosol precursor consumable, and an aerosol delivery device that comprises a control unit that defines a receiving chamber, and a removable and replaceable aerosol precursor consumable, at least a portion of the consumable configured to be received into the receiving chamber. The aerosol precursor consumable comprises a housing defining an outer wall, an aerosol precursor composition reservoir located in the housing and configured to contain an aerosol precursor composition, an atomizer located in the housing, and at least one aroma diffuser. The atomizer is configured to vaporize the aerosol precursor composition to generate an aerosol for oral delivery to a user, and the at least one aroma diffuser is configured to diffuse an aroma composition for olfactory delivery to the user.